Zhao Renbin
Vermögen: 143 Mio $ am 31.05.2026
Vermögen: 143 Mio $ am 31.05.2026
Zhao Renbin currently works at InnoCare Pharma Ltd., as Executive Director & VP-Regulatory Affairs.
Dr. Renbin also formerly worked at BioDuro (Beijing) Co., Ltd., as Director-Discovery Biology from 2013 to 2015 and Shenzhou Tianchen Technology, Inc., as Director from 2010 to 2013.
Dr. Renbin received her undergraduate degree in 1991 from Tsinghua University and doctorate degree in 1999 from The Johns Hopkins University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INNOCARE PHARMA LTD. 6,45 % | 30.04.2026 | 96.453.375 ( 6,45 % ) | 143 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOCARE PHARMA LIMITED | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research and development services | Corporate Officer/Principal | 01.08.2015 |
Shenzhou Tianchen Technology, Inc. | Direktor/Vorstandsmitglied | 01.03.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research and development services | Commercial Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InnoCare Pharma Ltd.
InnoCare Pharma Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of cancer and autoimmune diseases | Health Technology |
Shenzhou Tianchen Technology, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen